Dian Diagnostics: Controlling shareholder releases part of share pledge

Dian Diagnostics Group (SZSE:300244) announced that its controlling shareholder, Chen Haibin, has completed procedures to release a portion of his pledged shares. A total of 12.4 million shares were released, representing 0.17% of his holdings and 1.98% of the company's total share capital, pledged to China Merchants Securities. Following the release, Chen Haibin and his consistent actor, Hangzhou Dian Holding Co., Ltd., have a combined total of 86.36 million shares pledged, accounting for 52.52% of their holdings and 13.82% of Dian Diagnostics' total share capital. The announcement assures that the share pledge does not pose a risk of forced liquidation and will not lead to a change in control of the company.